Articles
Personalised medicine: a view from Roche

Personalised medicine: a view from Roche

We interview Dr Horst Kramer of Roche on his definition of personalised medicine, the importance of clear communication in this area and the need for reliable diagnostics. Personalised medicine has received a lot of hype in the media. Over-promising and exaggerations have led to…

Articles
Patient feedback data for health economic modelling: the patient´s voice integrated

Patient feedback data for health economic modelling: the pat...

DRs Nadine van Dongen explains the importance of the patient’s voice in clinical feedback data and shares her thoughts on the future of health economic evaluations. Up to now, the reimbursement of new innovative pharmaceuticals was merely based on registration data...

Articles
Planning a chart-topping mobile pharma project

Planning a chart-topping mobile pharma project

Following our mobile health theme, Michael Ashworth shares his top tips to planning and building a successful mobile pharma project. Building mobile apps and websites is often at the very top of pharma company marketing to-do lists...

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. ESMO26: Tango sees 82% ORR with combo in pancreatic cancer
  2. Roche offers $15bn for strategic-level deal with Hansoh
  3. ESMO26: Moderna, MSD reveal cancer jab data early after leak
  4. Clinical trial setup times fall sharply in UK
  5. Despite US policy changes, drug prices stay stubbornly high

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more